FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment
March 10, 2025
The FDA recently approved. AXS-07 is an oral, rapidly absorbed, mul...
Read More
Telehealth May Help People Stick with Alcoholism Treatment
May 6, 2024
Alcohol use disorder (AUD) is widespread in the United States, yet ...
Read More
Antidepressant Use and Impulse Control Disorder in Parkinson's Disease
January 28, 2024
A recent study suggests a temporal association between the use of s...
Read More
Epigenetic Association With MDMA-Assisted Therapy Treatment Response For Severe PTSD
March 6, 2023
ost-traumatic stress disorder (PTSD) has historically been difficul...
Read More
Genetic Risk for Obsessive-Compulsive Disorder
March 3, 2023
The question of whether psychiatric conditions arise from genetic o...
Read More
'Convincing Evidence' Hearing Aids Reduce Dementia Risk
December 20, 2022
With no truly effective treatment for dementia yet available, there...
Read More
Imaging IDs Brain Activity Related to Dissociative Symptoms
November 24, 2022
In a study of nearly 100 women, participants with certain dissociat...
Read More
Antidepressants in Pregnancy Aren't Linked to Increased Neurological Issues in Children
October 16, 2022
In a recent cohort study, the relationship between in utero exposur...
Read More
ADHD and Risk of Migraine
July 5, 2022
A recent longitudinal case-cohort study shows children and adolesce...
Read More
Role Of The Oral-Gut-Microbiome-Brain Axis In Trauma-Related Disorders
February 23, 2022
The microbiome-gut-brain axis has been proposed as a moderator or m...
Read More
Psilocybin Therapy Increases Cognitive And Neural Flexibility In Patients With Major Depressive Disorder
November 18, 2021
Psilocybin therapy has shown promise in treating major depressive d...
Read More
2021 NEI Congress Young Investigator Poster Competition Winners
November 5, 2021
The 2021 NEI Congress Scientific Poster Session and Reception was h...
Read More